Overview
- Oracle reported in March 2026 that its remaining performance obligations, a measure of contracted future revenue, had reached $553 billion, signaling large, multi‑year demand for AI compute capacity.
- The company plans to sharply raise capital spending to about $50 billion for the fiscal year and has closed project bonds and a $1.65 billion Datapod supply deal to finance new U.S. and European data centers.
- Some sell‑side analysts have grown more bullish and raised price targets, citing visible demand and contract backing, with firms like Wedbush and Oppenheimer maintaining Outperform ratings.
- Investors remain worried about rising leverage, negative near‑term free cash flow from the capex ramp, concentration of major customers such as OpenAI, and the timing risk of turning RPO into recognized revenue and cash.
- Oracle is expanding commercial use cases beyond hyperscalers, including an African Clinical Research Network collaboration for AI‑powered trials, and the market will watch delivery pace, customer funding, and free‑cash‑flow trends next.